Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bock

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Tuberculosis in the inner city: impact of a continuing epidemic in the 1990sM J Sotir, P Parrott, B Metchock, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2015
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBIE E Bliven-Sizemore, T R Sterling, N Shang, et al.
The American Review of Respiratory Disease|February 1, 1988
Effects of ambient ozone on respiratory function in active, normal childrenD M Spektor, M Lippmann, P J Lioy, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2002
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatmentNaomi N Bock, Timothy R Sterling, Carol D Hamilton, et al.
Plos One|April 12, 2014
Age-dependent effects of UCP2 deficiency on experimental acute pancreatitis in miceSarah Müller, Hannah Kaiser, Burkhard Krüger, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 6, 2013
A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetesDavid Arterburn, David R Flum, Emily O Westbrook, et al.
Frontiers in Cellular and Infection Microbiology|July 6, 2017
Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 CellsCristin N Bock, Subash Babu, Minka Breloer, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standardsM E Villarino, M J Brennan, C M Nolan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistanceR Reves, C M Heilig, J M Tapy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapyS N Bock, R E Lee, B Fisher, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Tuberculosis in the inner city: impact of a continuing epidemic in the 1990sM J Sotir, P Parrott, B Metchock, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2015
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBIE E Bliven-Sizemore, T R Sterling, N Shang, et al.
The American Review of Respiratory Disease|February 1, 1988
Effects of ambient ozone on respiratory function in active, normal childrenD M Spektor, M Lippmann, P J Lioy, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2002
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatmentNaomi N Bock, Timothy R Sterling, Carol D Hamilton, et al.
Plos One|April 12, 2014
Age-dependent effects of UCP2 deficiency on experimental acute pancreatitis in miceSarah Müller, Hannah Kaiser, Burkhard Krüger, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 6, 2013
A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetesDavid Arterburn, David R Flum, Emily O Westbrook, et al.
Frontiers in Cellular and Infection Microbiology|July 6, 2017
Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 CellsCristin N Bock, Subash Babu, Minka Breloer, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Comparison testing of current (PPD-S1) and proposed (PPD-S2) reference tuberculin standardsM E Villarino, M J Brennan, C M Nolan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistanceR Reves, C M Heilig, J M Tapy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapyS N Bock, R E Lee, B Fisher, et al.
Pageof 8